Outcome of Board Meeting
With reference to the Regulation 30, Please find the enclosed documents in terms of Regulation 33 of SEBI (LODR) Regulations, 2015: Un-Audited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September, 2018. Limited Review Report on Standalone and Consolidated Financials Results for the second quarter and half year ended 30th September, 2018. Results For The Second Quarter And Half Year Ended 30.09.2018
Please find the enclosed as below 1. unaudited standalone and consolidated financials results for the second quarter ended 30.09.2018. 2. Limited Review Report on standalone and consolidated financial results for the second quarter and half year ended 30.09.2018 this is for your information. Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations & Announcement Of Closure Of Trading Window
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve We wish to inform you that a meeting of Board of Directors will be held on Wednesday, the 14th day of November, 2018, inter alia to consider the Un-audited financial results for the second quarter ended 30th September, 2018 in compliance of Regulation 33 of the said regulations.... Certificate Under Regulation 40(9) Of SEBI (LODR), 2015 For Half Year Ended 30Th September, 2018
With reference to the subject cited above, please find attached herewith the certificate under regulation 40(9) of SEBI (LODR) Regulations, 2015, issued by the D.S. Rao, Practicing Company Secretary in P.S. Rao & Associates for half year ended 30th September, 2018 Kindly take the same on record. Compliance Certificate For The Half Year Ended 30.09.2018
With reference to the subject cited above, please find attached herewith the Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, issued by the Company and the RTA i.e. M/s. Karvy Computershare Private Limited. Kindly take the same on record. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Inani Shareholding for the Period Ended September 30, 2018
Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Compliance Certificate For The Half Year Ended 30.09.2018
With reference to the subject cited above, please find attached herewith the Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, issued by the Company and the RTA i.e. M/s. Karvy Computershare Private Limited. Kindly take the same on record. Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- MADHUSUDHAN REDDYDesignation :- Company Secretary and Compliance Officer Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Shilpa Medicare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here